31 results on '"Scilla, Katherine A."'
Search Results
2. Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
3. Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299
4. Immunotherapy in Lung Cancer: From a Minor God to the Olympus
5. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non–small-cell Lung Cancer Treated With Curative Intent
6. Phase II Trial of Nivolumab and Ramucirumab for Relapsed Mesothelioma: HCRN-LUN15-299
7. Immunotherapy in Lung Cancer: A New Age in Cancer Treatment
8. How I treat ALK-positive non-small cell lung cancer
9. Tracking clonal evolution of EGFR-mutated non-small cell lung cancer through liquid biopsy: Management of C797S acquired mutation
10. Targeted Therapies (Small Molecules)
11. Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies
12. New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
13. Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools
14. Abstract OT3-13-01: First in Human Study of AG01 a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88)
15. PP01.74 LiquidHALLMARK detects more tissue-confirmed guideline-recommended biomarkers than Guardant360 for lung cancer: a prospective multicenter study
16. Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report
17. NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)
18. RET fusions in solid tumors
19. Long-term efficacy of immune checkpoint inhibitors in advanced NSCLC: challenges and opportunities—a commentary of the 3-year follow-up of the KEYNOTE-001 trial
20. Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC
21. Liquid biopsy tracking of lung tumor evolutions over time
22. Proton Beam Therapy and Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma
23. Immunotherapy Use in Patients with HIV and Non-Small-Cell Lung Cancer: Current Data
24. The Role of Circulating Tumor DNA in Lung Cancer: Mutational Analysis, Diagnosis, and Surveillance Now and into the Future
25. Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection
26. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy
27. Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer (CA) patients (pts) with and without human immunodeficiency virus (HIV) infection.
28. Case-control study of PD-1, PD-L1, and B7-H3 expression in human immunodeficiency virus infected (HIV+) and uninfected patients with head and neck cancers.
29. PD-1, PD-L1, and B7-H3 expression in Human Immunodeficiency Virus (HIV) infected patients with aerodigestive (AD) cancers (CA).
30. A phase 1a/1b study of aurora kinase A inhibitor VIC-1911 as monotherapy and in combination with sotorasib for the treatment of KRAS G12C -mutant non–small-cell lung cancer.
31. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.